Form 4 for ADCT ADC Therapeutics SA
Accepted 2025-06-17 00:00:00 ET · period of report 2025-06-13 · accession 0001628280-25-031891 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-17 | 2025-06-13 | ADCT | BIZZARI JEAN-PIERRE | Dir | F - Tax | $3.58 | -12.6K | 106.9K | -11% | -$45.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-06-13 | F | D | 12,600 | $3.58 | 106,902 | D | — | — |